ArticleMagnetic resonance imaging2020
Free-breathing dynamic contrast-enhanced magnetic resonance of interstitial lung fibrosis.
Article in Magnetic resonance imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent.Chemical & biomedical imaging · 2023Article
- Dynamic Contrast-enhanced MRI Demonstrates Pulmonary Microvascular Abnormalities Months After SARS-CoV-2 Infection.American journal of respiratory and critical care medicine · 2023Article
- Dynamic contrast-enhanced magnetic resonance imaging of the lung reveals important pathobiology in idiopathic pulmonary fibrosis.ERJ open research · 2021Article
- PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis.European journal of nuclear medicine and molecular imaging · 2021Article
- Novel Imaging Strategies in Systemic Sclerosis.Current rheumatology reports · 2020Review
- New Insight into Laboratory Tests and Imaging Modalities for Fast and Accurate Diagnosis of COVID-19: Alternative Suggestions for Routine RT-PCR and CT-A Literature Review.Canadian respiratory journal · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeComputed tomography (CT) imaging is the standard to assess interstitial lung disease. Magnetic resonance (MR) is potentially advantageous due to superior tissue characterization and better assessment of blood flow dynamics. This study aimed to evaluate idiopathic pulmonary fibrosis (IPF) using prototype 4D Stack of Stars GRE (StarVIBE) MR and compare it to CT.
methodThis IRB-approved prospective study included 13 patients [5F:8M; average age 66 ± 8.1 years] with pulmonary fibrosis, and 12 healthy controls [3F:9M; average age 55 ± 3.6 years]. MR of the chest included noncontrast steady-state free precession imaging (SSFP) and free-breathing 4D StarVIBE sequence with intravenous contrast administration up to 160 s. The images were assessed for quality and artifacts. The image resolution was evaluated based on the visibility of the smallest bronchi, vessels, lymph nodes, and pleural fissures. Independent assessment of reticulation, ground-glass opacity, and traction bronchiectasis was performed and compared to CT.
resultsThe StarVIBE images had fewer artifacts and higher spatial resolution. The findings associated with IPF were significantly better seen with StarVIBE, with superior CT correlation.
conclusionContrast-enhanced free-breathing StarVIBE MR can generate high quality images with good correlation to CT in patients with IPF, and with high spatial and temporal resolution to generate rapid sequential dynamic images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.